Biotechnology
Cannabinoid Biosynthesis Market

Cannabinoid Biosynthesis Market Size, Share, and Growth Forecast, 2025 - 2032

Cannabinoid Biosynthesis Market by Product Type (Phytocannabinoids, Synthetic Cannabinoids, Endocannabinoid System, Modulators, Cannabinoids), Source (Cannabis Sativa, Cannabis Indica, Hemp-Derived Cannabinoids, Others), Application, and Regional Analysis for 2025 - 2032

ID: PMRREP32885

September 2025

191 Pages

Author : Pravin Rewale

Healthcare

Preview Segmentation

Cannabinoid Biosynthesis Market Size and Trends Analysis

The global cannabinoid biosynthesis market size is likely to grow from US$2.6 Bn in 2025 to US$6.6 Bn by 2032, registering a CAGR of 14.2% during the forecast period from 2025 to 2032.

Key Industry Highlights:

Leading Region: North America holds a 41% market share in 2025, driven by advanced biotechnology infrastructure, high consumer awareness, and strong adoption of innovative biosynthesis solutions in the U.S.
Fastest-growing Region: Asia Pacific, fueled by rising investments in biotech materials, increasing adoption of wellness products, and expanding facilities in countries such as China and India.
Dominant Product Type: Phytocannabinoids account for 60% of the global cannabinoid biosynthesis market share, driven by their critical role in providing renewable and consistent options for various applications.
Leading Application: Pharmaceuticals leads with a 50% share, reflecting high global demand for biosynthesis-enhanced sustainable production.
Key Growth Driver: Legalization trends and medical research initiatives are boosting demand, with biosynthesized cannabinoids reducing cultivation dependency by up to 30% in key sectors.

global-cannabinoid-biosynthesis-market-size-2025–2032

Global Market Attribute	Key Insights
Cannabinoid Biosynthesis Market Size (2025E)	US$2.6 Bn
Market Value Forecast (2032F)	US$6.6 Bn
Projected Growth (CAGR 2025 to 2032)	14.2%
Historical Market Growth (CAGR 2019 to 2024)	13.6%

The cannabinoid biosynthesis market has experienced steady growth, driven by increasing demand for sustainable production methods, advancements in biotechnology and synthetic biology, and rising consumer preference for high-purity, consistent cannabinoid products as alternatives to traditional plant extraction with reduced environmental impact.

Market Dynamics

Driver - Rising Demand for Sustainable Production Methods Pushes Demand

The global increase in sustainable cannabinoid production and consumption is driving growth in the cannabinoid biosynthesis market. Rising demand for eco-friendly alternatives to traditional cultivation, supported by environmental awareness and evolving consumer preferences, is creating opportunities for bio-engineered and scalable products.

Cannabinoids produced through microbial fermentation and yeast-based platforms, such as those using engineered organisms to synthesize CBD and THC, are widely used to enhance sustainability, improve purity levels, and reduce water and land usage, ensuring lower environmental impact.

With growing interest in green and clean-label wellness solutions, biosynthesized cannabinoids provide precise, contaminant-free options for medical and consumer improvement, supporting sustained market expansion across both developed and emerging regions. Their adoption in pharmaceuticals is particularly important where consistency is critical.

Additionally, global legalization efforts, with dozens of countries permitting medical cannabis in recent years, have amplified demand, as biosynthesis allows for cost-effective scaling without agricultural risks such as weather variability or pesticide contamination.

Statistics from the World Health Organization indicate that sustainable biotech approaches could significantly cut carbon emissions in cannabinoid production, further justifying investments from major players. This driver is bolstered by R&D advancements, such as CRISPR gene editing in host organisms, which have notably reduced production times in recent trials, enabling faster market entry and broader application in therapeutics for conditions such as epilepsy and chronic pain.

Restraint - High Costs and Regulatory Challenges Restrict Adoption

The cannabinoid biosynthesis market faces substantial restraints that limit its pace of growth and scalability. One of the foremost challenges is the elevated cost of establishing biotechnology infrastructure and developing engineered microbial strains, which often requires multimillion-dollar R&D investments. Such high entry costs make it difficult for startups and smaller enterprises to participate, concentrating opportunities among well-capitalized players.

In addition, the regulatory landscape is complex and restrictive, with agencies such as the FDA and EMA imposing rigorous approval processes that can take several years to complete, delaying commercialization and adding heavy compliance expenses.

Intellectual property disputes surrounding biosynthesis patents further complicate the cannabinoid biosynthesis market, creating legal uncertainty and discouraging partnerships or new entrants. Alongside these structural barriers, public skepticism toward synthetic biology and cultural resistance in regions with stricter cannabis policies present hurdles for consumer and regulatory acceptance. Collectively, these challenges hinder innovation, slow the scale-up of production, and restrict the widespread adoption of biosynthesized cannabinoids across global markets.

Opportunity - Innovation in Eco-Friendly and Functional Cannabinoids Boosts Consumption

Emerging innovations in biosynthesis technologies present a significant opportunity for the expansion of the cannabinoid biosynthesis market. By leveraging advanced metabolic engineering, manufacturers can now produce rare cannabinoids such as cannabigerol (CBG) and cannabinol (CBN), which are typically available only in trace amounts through plant extraction.

These compounds are gaining strong interest for their promising anti-inflammatory, neuroprotective, and therapeutic potential, opening pathways to premium pharmaceutical applications. Beyond traditional healthcare, the ability to design cannabinoids with enhanced bioavailability and targeted therapeutic effects creates opportunities in fast-growing niches such as pet wellness, sports nutrition, and functional food supplements.

Strategic collaborations between biotech innovators and global pharmaceutical companies are expected to accelerate commercialization, streamline regulatory pathways, and expand clinical research efforts. In addition, rising government support for sustainable biotechnology through grants and funding programs is helping reduce production costs and improve scalability. Together, these factors position biosynthesized cannabinoids as a transformative opportunity, driving innovation, diversification, and market growth worldwide.

Get Your CustomizationGet Your Customization

Category-wise Analysis

Product Type Insights

The cannabinoid biosynthesis market is segmented into phytocannabinoids, synthetic cannabinoids, endocannabinoid system, modulators, and cannabinoids. Phytocannabinoids dominate, holding approximately 60% market share in 2025, due to their critical role in providing renewable, bio-identical options for applications in pharmaceuticals. Advanced formulations from Demetrix are widely adopted for their reliability and efficiency in sustainable manufacturing.

Synthetic cannabinoids are the fastest-growing segment, driven by increasing demand for cannabinoids that enhance purity and versatility in tailored materials. Innovations in high-efficiency variants from Ginkgo Bioworks improve product quality, boosting adoption in industrial and premium applications, particularly in cosmetics and wellness.

Source Insights

The cannabinoid biosynthesis market is divided into cannabis sativa, cannabis indica, hemp-derived cannabinoids, and others. Hemp-derived cannabinoids lead with a 45% share in 2025, driven by high global demand for basic biosynthesis sources, with millions of units produced annually for their sustainability and versatility in pharmaceutical and food applications.

Cannabis sativa is the fastest-growing segment, fueled by rising demand for advanced and customized offerings in manufacturing. The success of functional sources in creating high-quality, specialty products drives adoption in healthcare and aromatherapy across diverse markets.

Application Insights

The cannabinoid biosynthesis market is segmented into pharmaceuticals, food and beverages, cosmetics and personal care, healthcare products, and aromatherapy and wellness. Pharmaceuticals dominate, holding approximately 50% market share in 2025, due to their critical role in sustainable production, consistency, and extended therapeutic efficacy. Formulations from Jazz Pharmaceuticals PLC are widely adopted for their reliability in commercial applications.

Food and beverages are the fastest-growing segment, driven by demand for cannabinoids that enhance eco-friendliness and performance in specialty products. Innovations from Canopy Growth Corp improve quality, boosting adoption in green and premium applications, particularly in wellness and consumer goods.

global-cannabinoid-biosynthesis-market-outlook-by-application-2025–2032

Regional Insights

North America Cannabinoid Biosynthesis Market Trends

North America dominates the global market, expected to account for 41% market share in 2025, driven by advanced biotechnology infrastructure, high consumer demand for sustainable cannabinoids, and strong adoption of innovative biosynthesis solutions.

The demand for phytocannabinoids is surging, fueled by the popularity of eco-friendly, consistent products in retail and industrial sectors. Leading brands such as Demetrix and Ginkgo Bioworks are introducing biotechnology-integrated platforms tailored to enhance purity and sustainability.

The U.S. market trends are particularly noteworthy, with federal legalization progress and state-level initiatives accelerating growth. In the U.S., the cannabinoid biosynthesis market is propelled by robust R&D funding, with significant investments directed toward biotech startups focusing on yeast-based cannabinoid production.

Trends include the rise of medical-grade biosynthesized CBD for epilepsy treatments, as seen in FDA-approved products, and consumer shifts toward THC-free wellness items. Companies such as Amyris Inc are leveraging partnerships with pharmaceutical firms to expand in states such as California and Colorado, where recreational markets drive innovation in scalable production.

Europe Cannabinoid Biosynthesis Market Trends

Europe is dominated by Germany, the U.K., and France, benefiting from strong regulatory support and rising demand for sustainable products. Germany leads with a substantial market share, where players such as Evolva Holding SA and Willow Biosciences Inc address demand for synthetic cannabinoids in large-scale industrial applications. The EU’s environmental regulations and sustainability initiatives encourage eco-label biosynthesis solutions, strengthening innovation and consumer trust.

In the U.K., market expansion is driven by functional cannabinoid formulations, with Hyasynth Biologicals introducing advanced solutions for premium and green manufacturers. France shows strong growth in healthcare applications, with CB Therapeutics providing specialized offerings for professional industries. Supportive policies promoting biotech materials enhance regional opportunities, creating a diverse and competitive landscape for long-term growth.

Asia Pacific Cannabinoid Biosynthesis Market Trends

Asia Pacific is the fastest-growing region, led by China, India, and Japan. In China, the rapid expansion of biotech manufacturing, coupled with the rising middle-class population’s preference for wellness goods, boosts demand for advanced cannabinoid formulations. Companies such as Zymergen Inc customize offerings for local requirements, strengthening adoption in commercial segments.

India’s market is driven by consumer preference for green products and government initiatives such as the Biotechnology Industry Research Assistance Council, which promotes bio-processing modernization. Domestic players such as Renew Biopharma offer cost-effective, high-performance solutions.

In Japan, high-tech and functional cannabinoid applications cater to premium production, with InMed Pharmaceuticals gaining traction. The growth of e-commerce platforms enhances product accessibility, supporting sustained market expansion.

global-cannabinoid-biosynthesis-market-outlook-by-region-2025–2032

Request Free sampleRequest Free sample

Competitive Landscape

The global cannabinoid biosynthesis market is highly competitive, with global and regional players competing on innovation, affordability, and compliance with regulatory standards. The rise of bio-engineered and functional cannabinoids intensifies competition, as companies meet stringent quality requirements and consumer demands for sustainable products. Strategic partnerships, acquisitions, and technological advancements are key differentiators.

Key Developments

December 2024: Brains Bioceutical Corp expanded its cannabinoid API offerings, introducing cannabinol (CBN) as an EU-GMP certified API, while advancing stability optimization for crystalline THC and final validation of cannabigerol (CBG). Their growing API portfolio supports regulatory-compliant clinical programs in areas such as neurological disorders, chronic pain, and inflammatory conditions.
May 2025: Benuvia Operations entered into a research and manufacturing agreement with Trait Biosciences to accelerate the commercialization of next-generation water-soluble cannabinoids. Under this collaboration, Benuvia will scale up and validate manufacturability of Trait’s lead synthetic THC derivatives and expand to other cannabinoid variants.

Companies Covered in Cannabinoid Biosynthesis Market

Demetrix
Ginkgo Bioworks
Hyasynth Biologicals
Creo
Amyris Inc
Zymergen Inc
Cronos Group Inc
Constellation Brands Inc
Jazz Pharmaceuticals PLC
Canopy Growth Corp
Evolva Holding SA
Willow Biosciences Inc
InMed Pharmaceuticals
CB Therapeutics
Lygos
Purisys
Renew Biopharma
Others

Frequently Asked Questions

The cannabinoid biosynthesis market is projected to reach US$2.6 Bn in 2025.

Rising demand for sustainable production methods, advancements in biotechnology, and government legalization initiatives are key drivers.

The cannabinoid biosynthesis market is poised to witness a CAGR of 14.2% from 2025 to 2032.

Innovation in eco-friendly and functional cannabinoids presents significant growth opportunities.

Demetrix, Ginkgo Bioworks, and Hyasynth Biologicals are among the key market players.

Report Attribute	Details
Historical Data/Actuals	2019 2024
Forecast Period	2025 2032
Market Analysis	Value: US$ Bn, Volume: As Applicable
Geographical Coverage	North America Europe East Asia South Asia and Oceania Latin America
Segmental Coverage	Product Type Source Application Region
Competitive Analysis	Demetrix Ginkgo Bioworks Hyasynth Biologicals Creo Amyris Inc Zymergen Inc Cronos Group Inc Constellation Brands Inc Jazz Pharmaceuticals PLC Canopy Growth Corp Evolva Holding SA Willow Biosciences Inc InMed Pharmaceuticals CB Therapeutics Lygos Purisys Renew Biopharma Others
Report Highlights	Market Forecast and Trends Competitive Intelligence and Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Pricing Analysis Future Opportunities and Revenue Pockets Market Analysis Tools

Top-Down Market Sizing	Bottom-Up Market Sizing
Universe Definition: Total global/regional market identification	Unit Economics: Average transaction values, purchase frequencies, customer lifecycle
Segmentation Filters: Geographic, demographic, and behavioral constraints	Customer Segmentation: Detailed buyer persona development and sizing
Market Share Analysis: Competitive landscape assessment and share allocation	Penetration Analysis: Market penetration rates by segment and geography
Growth Rate Application: Historical trends and forward-looking growth assumptions	Scaling Methodology: Extrapolation techniques with confidence intervals

Interested in this report?

Request customization, ask for expert consulting, access a sample report, or simply express your interest—our team will assist you with the right insights and solutions.

Request Custom VersionRequest Custom Version

Clients

Media Citation

Get In Touch

Loading page data

Please wait a moment

Global Market Attribute

Key Insights

Cannabinoid Biosynthesis Market Size (2025E)

US$2.6 Bn

Market Value Forecast (2032F)

US$6.6 Bn

Projected Growth (CAGR 2025 to 2032)

14.2%

Historical Market Growth (CAGR 2019 to 2024)

13.6%

Report Attribute	Details
Historical Data/Actuals	2019 2024
Forecast Period	2025 2032
Market Analysis	Value: US$ Bn, Volume: As Applicable
Geographical Coverage	North America Europe East Asia South Asia and Oceania Latin America
Segmental Coverage	Product Type Source Application Region
Competitive Analysis	Demetrix Ginkgo Bioworks Hyasynth Biologicals Creo Amyris Inc Zymergen Inc Cronos Group Inc Constellation Brands Inc Jazz Pharmaceuticals PLC Canopy Growth Corp Evolva Holding SA Willow Biosciences Inc InMed Pharmaceuticals CB Therapeutics Lygos Purisys Renew Biopharma Others
Report Highlights	Market Forecast and Trends Competitive Intelligence and Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Pricing Analysis Future Opportunities and Revenue Pockets Market Analysis Tools

Executive Summary
1. Global Cannabinoid Biosynthesis Market Snapshot, 2025 and 2032
2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Challenges
  5. Key Trends
3. COVID-19 Impact Analysis
4. Forecast Factors - Relevance and Impact
Value Added Insights
1. Value Chain Analysis
2. Key Market Players
3. Regulatory Landscape
4. PESTLE Analysis
5. Porter’s Five Force Analysis
6. Consumer Behavior Analysis
Price Trend Analysis, 2019 - 2032
1. Key Factors Impacting Product Prices
2. Pricing Analysis, By Product Type
3. Regional Prices and Product Preferences
Global Cannabinoid Biosynthesis Market Outlook
1. Market Size (US$ Bn) Analysis and Forecast
  1. Historical Market Size (US$ Bn) Analysis, 2019-2024
  2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
2. Global Cannabinoid Biosynthesis Market Outlook: Product Type
  1. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019-2024
  2. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    1. Phytocannabinoids
    2. Synthetic Cannabinoids
    3. Endocannabinoid System
    4. Modulators
    5. Cannabinoids
  3. Market Attractiveness Analysis: Product Type
3. Global Cannabinoid Biosynthesis Market Outlook: Source
  1. Historical Market Size (US$ Bn) Analysis, By Source, 2019-2024
  2. Market Size (US$ Bn) Analysis and Forecast, By Source, 2025-2032
    1. Cannabis Sativa
    2. Cannabis Indica
    3. Hemp-Derived Cannabinoids
    4. Others
  3. Market Attractiveness Analysis: Source
4. Global Cannabinoid Biosynthesis Market Outlook: Application
  1. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
  2. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    1. Pharmaceuticals
    2. Food and Beverages
    3. Cosmetics and Personal Care
    4. Healthcare Products
    5. Aromatherapy and Wellness
    6. Others
  3. Market Attractiveness Analysis: Application
Global Cannabinoid Biosynthesis Market Outlook: Region
1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
  1. North America
  2. Latin America
  3. Europe
  4. East Asia
  5. South Asia and Oceania
  6. Middle East & Africa
3. Market Attractiveness Analysis: Region
North America Cannabinoid Biosynthesis Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Product Type
  3. By Source
  4. By Application
2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  1. U.S.
  2. Canada
3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
  1. Phytocannabinoids
  2. Synthetic Cannabinoids
  3. Endocannabinoid System
  4. Modulators
  5. Cannabinoids
4. Market Size (US$ Bn) Analysis and Forecast, By Source, 2025-2032
  1. Cannabis Sativa
  2. Cannabis Indica
  3. Hemp-Derived Cannabinoids
  4. Others
5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  1. Pharmaceuticals
  2. Food and Beverages
  3. Cosmetics and Personal Care
  4. Healthcare Products
  5. Aromatherapy and Wellness
  6. Others
6. Market Attractiveness Analysis
Europe Cannabinoid Biosynthesis Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Product Type
  3. By Source
  4. By Application
2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Rest of Europe
3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
  1. Phytocannabinoids
  2. Synthetic Cannabinoids
  3. Endocannabinoid System
  4. Modulators
  5. Cannabinoids
4. Market Size (US$ Bn) Analysis and Forecast, By Source, 2025-2032
  1. Cannabis Sativa
  2. Cannabis Indica
  3. Hemp-Derived Cannabinoids
  4. Others
5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  1. Pharmaceuticals
  2. Food and Beverages
  3. Cosmetics and Personal Care
  4. Healthcare Products
  5. Aromatherapy and Wellness
  6. Others
6. Market Attractiveness Analysis
East Asia Cannabinoid Biosynthesis Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Product Type
  3. By Source
  4. By Application
2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  1. China
  2. Japan
  3. South Korea
3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
  1. Phytocannabinoids
  2. Synthetic Cannabinoids
  3. Endocannabinoid System, Modulators, Cannabinoids
4. Market Size (US$ Bn) Analysis and Forecast, By Source, 2025-2032
  1. Cannabis Sativa
  2. Cannabis Indica
  3. Hemp-Derived Cannabinoids
  4. Others
5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  1. Pharmaceuticals
  2. Food and Beverages
  3. Cosmetics and Personal Care
  4. Healthcare Products
  5. Aromatherapy and Wellness
  6. Others
6. Market Attractiveness Analysis
South Asia & Oceania Cannabinoid Biosynthesis Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Product Type
  3. By Source
  4. By Application
2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  1. India
  2. Indonesia
  3. Thailand
  4. Singapore
  5. ANZ
  6. Rest of South Asia & Oceania
3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
  1. Phytocannabinoids
  2. Synthetic Cannabinoids
  3. Endocannabinoid System
  4. Modulators
  5. Cannabinoids
4. Market Size (US$ Bn) Analysis and Forecast, By Source, 2025-2032
  1. Cannabis Sativa
  2. Cannabis Indica
  3. Hemp-Derived Cannabinoids
  4. Others
5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  1. Pharmaceuticals
  2. Food and Beverages
  3. Cosmetics and Personal Care
  4. Healthcare Products
  5. Aromatherapy and Wellness
  6. Others
6. Market Attractiveness Analysis
Latin America Cannabinoid Biosynthesis Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Product Type
  3. By Source
  4. By Application
2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  1. Brazil
  2. Mexico
  3. Rest of Latin America
3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
  1. Phytocannabinoids
  2. Synthetic Cannabinoids
  3. Endocannabinoid System
  4. Modulators
  5. Cannabinoids
4. Market Size (US$ Bn) Analysis and Forecast, By Source, 2025-2032
  1. Cannabis Sativa
  2. Cannabis Indica
  3. Hemp-Derived Cannabinoids
  4. Others
5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  1. Pharmaceuticals
  2. Food and Beverages
  3. Cosmetics and Personal Care
  4. Healthcare Products
  5. Aromatherapy and Wellness
  6. Others
6. Market Attractiveness Analysis
Middle East & Africa Cannabinoid Biosynthesis Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  1. By Country
  2. By Product Type
  3. By Source
  4. By Application
2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
  1. Phytocannabinoids
  2. Synthetic Cannabinoids
  3. Endocannabinoid System
  4. Modulators
  5. Cannabinoids
4. Market Size (US$ Bn) Analysis and Forecast, By Source, 2025-2032
  1. Cannabis Sativa
  2. Cannabis Indica
  3. Hemp-Derived Cannabinoids
  4. Others
5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  1. Pharmaceuticals
  2. Food and Beverages
  3. Cosmetics and Personal Care
  4. Healthcare Products
  5. Aromatherapy and Wellness
  6. Others
6. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2024
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. Demetrix
    1. Overview
    2. Segments and Product Type
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Ginko Bioworks
  3. Hyasynth Biologicals
  4. Creo
  5. Amyris Inc
  6. Zymergen Inc
  7. Cronos Group Inc
  8. Constellation Brands Inc
  9. Jazz Pharmaceuticals PLC
  10. Canopy Growth Corp
  11. Evolva Holding SA
  12. Willow Biosciences Inc
  13. InMed Pharmaceuticals
  14. CB Therapeutics
  15. Lygos
  16. Purisys
  17. Renew Biopharma
  18. Others
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Cannabinoid Biosynthesis Market Size, Share, and Growth Forecast, 2025 - 2032

Cannabinoid Biosynthesis Market by Product Type (Phytocannabinoids, Synthetic Cannabinoids, Endocannabinoid System, Modulators, Cannabinoids), Source (Cannabis Sativa, Cannabis Indica, Hemp-Derived Cannabinoids, Others), Application, and Regional Analysis for 2025 - 2032